To test whether IL-6 can directly mediate resistance to doxorubicin, we cultured leukemia cells in the presence of IL-6, sIL-6R, or both IL-6 and sIL-6R to simulate signaling through sIL-6R-IL-6 complexes. This evidence concerns the gene IL6 and leukemia.